Related Experiment Video

Updated: Aug 16, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

On the nature of cancer and why anticancer vaccines don't work

Richmond T Prehn1

  • 1Dept of Pathology, University of Washington, 5433 South Hudson Street, Seattle, WA 98118, USA. prehn@u.washington.edu

Cancer Cell International
|August 3, 2005
PubMed

Insights

Developing effective anti-cancer vaccines is challenging because most cancers exhibit low immunogenicity due to scarce tumor-specific antigens. Tumor mutations may occur in silenced genes, and immune responses can paradoxically stimulate tumor growth.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Vaccinology

Background:

  • Effective anti-cancer vaccines are crucial for cancer treatment.
  • Current challenges hinder the development of potent cancer vaccines.

Purpose of the Study:

  • To identify the primary obstacles in creating effective anti-cancer vaccines.
  • To explore the reasons behind the low immunogenicity of most cancers.

Main Methods:

  • Conceptual analysis of tumor immunology and cancer genetics.
  • Review of existing literature on tumor antigenicity and immune response.

Main Results:

  • Most cancers possess limited immunogenicity due to a lack of tumor-specific antigens.
  • Genomic instability in tumors may result from mutations in silenced genes.
  • Immune responses to low or moderate amounts of tumor antigens can promote tumor growth.

Conclusions:

  • The scarcity of tumor-specific antigens is a major hurdle for anti-cancer vaccine development.
  • Understanding the role of silenced genes and immune stimulatory effects is key to advancing cancer vaccinology.

More Related Videos

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle12:19

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...